Posts

Showing posts with the label Stem Cell Therapy Market

Stem Cell Therapy Market Size, Market Dynamics, Factors Leading the Development, And Forecasts to 2030

Image
Stem cell therapy market was valued at over US$ 103 Mn in 2018 and is anticipated to grow at a CAGR of 9.8% from 2019 to 2030. The major factors driving the growth of the market includes increasing burden of chronic diseases, growing investment in R&D, and technological developments in biotech and pharmaceutical industry. Increasing global burden of diseases such as diabetes, cancer, and others are projected to be the major factors leading to the market growth. According to the World Health Organization (WHO) in 2017, number of patients suffering from type I and type II diabetes was estimated to be over 422 million. Moreover, the disease is expected to be the seventh largest cause of death by 2030. Major Key Players of the Stem Cell Therapy Market are: Osiris, MEDIPOST, Anterogen, PHARMICELL Co., Ltd, Holostem Terapie Avanzate S.r.l.JCR Pharmaceuticals Co., NuVasive, Inc.,  RTI Surgical, Inc , and  AlloSource Read More @  https://www.medgadget.com/2020/11/stem-cell-th...

Stem Cell Therapy Market Emerging Technological Advancement, Future Scope and Business Growth 2030 - Osiris, MEDIPOST, Anterogen

Image
Stem cells are cells which have the ability to differentiate into various types of other cells and ultimately form organs or tissues. Stem cells are mainly of two type embryonic stem cells and adult stem cells. Over the years many researchers have carried out studies to evaluate the true potential of stem cells leading to various applications in the field of organ regeneration, genetic diseases treatment, oncology and cell therapy in damaged cells. Market Industry Reports (MIR) has published a new report titled " Stem Cell Therapy Market  - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report The global stem cell therapy market was valued at over US$ 103 Mn in 2018 and is anticipated to grow at a CAGR of 9.8% from 2019 to 2030. The major factors driving the growth of the market include increasing burden of chronic diseases, growing investment in R&D, and technological developments in biotech and pharmaceutical industry....